The Award:DNA Software, Inc. (DNAS) announced today that they have been awarded the 2019 North American Enabling Technology Leadership Award from Frost & Sullivan. This prestigious recognition is based on extensive and ongoing analysis of the North American multiplex Read more ›
DNA Software CEO Dr. John SantaLucia, COO Norm Watkins and Research Scientist Holly SantaLucia participated in a recent Science paper was featured in the New York Times, CNN, NASA, Nature, and several other news outlets Read more ›
NEW YORK (GenomeWeb) – Fluidigm said today that it has entered into a non-exclusive distribution agreement with DNA Software to provide that firm’s CopyCount-CNV software for use with Fluidigm’s Biomark HD system.
Biomark HD is an Read more ›
DNA Software was featured in a recent article published in Nature on July 16, 2018 titled “Multiplexed identification, quantification and genotyping of infectious agents using a semiconductor biochip”. To learn more click here
Read more ›DNA Software Acknowledged and Referenced in Biology Methods & Protocols paper titled “An array-based melt curve analysis method for the identification and classification of closely related pathogen strains”.
Read more ›Click here to download a pdf copy of the DNA Software Spring Newsletter
Read more ›Large Scale Multiplex PCR Panel Design with >95% Success in Hours, Not Months
John SantaLucia, Ph.D., co-founder and CEO, DNA Software
Abstract: We aim to solve the problem of multiplex PCR design by Read more ›
Infectious disease molecular diagnostic(MDx) assays require rapid identification of pathogens and their drug resistance profiles in clinical samples use a highly multiplexed molecular approach. The market pull for such MDx assays has led to the software solution, Read more ›
ANN ARBOR, MICH. – At its annual meeting, Ann Arbor SPARK presented its annual FastTrack awards to 17 Washtenaw County-based companies that have demonstrated fast growth. Several of the 2016 and 2017 FastTrack award recipients Read more ›
Early identification of pathogens is essential for limiting development of therapy-resistant pathogens and mitigating infectious disease outbreaks. Most bacterial detection schemes use target-specific probes to differentiate pathogen species, creating time and cost inefficiencies in identifying Read more ›
